Intuitive Surgical, Inc. (ISRG) Operating Cash Flow CAGR:N/A(TTM)
The operating cash flow cagr for Intuitive Surgical, Inc. (ISRG) is N/A over the latest trailing 12-month period. Operating cash flow CAGR uses precomputed cash-flow statement history (cash from operations, before capital expenditures).
The operating cash flow cagr for Intuitive Surgical, Inc. (ISRG) stock is N/A over the past 12 months. The 3 year average growth rate is 27.03% and the 5 year cagr is 15.87%. Operating cash flow CAGR measures the compound annual growth rate of the cash Intuitive Surgical, Inc. generates from its core business operations, before capital expenditures, computed from rolling-twelve-month cash-flow statement history. The 1-year (TTM) figure is omitted: a one-year rate off a single quarter's base is volatile; the multi-year figures are the reliable read.
ISRG Operating Cash Flow CAGR Chart
Intuitive Surgical, Inc. (ISRG)
ISRG Operating Cash Flow CAGR History
| Year | Start OCF | End OCF | Change | % Change | CAGR |
|---|---|---|---|---|---|
| 2025 | $2.42B | $3.03B | +$615.50M | +25.49% | +25.49% |
| 2024 | $1.81B | $2.42B | +$601.20M | +33.15% | +33.15% |
| 2023 | $1.49B | $1.81B | +$323.00M | +21.67% | +21.67% |
| 2022 | $2.09B | $1.49B | $-598.60M | -28.65% | -28.65% |
| 2021 | $1.48B | $2.09B | +$604.60M | +40.72% | +40.72% |
| 2020 | $1.60B | $1.48B | $-113.40M | -7.10% | -7.10% |
| 2019 | $1.17B | $1.60B | +$428.60M | +36.65% | +36.65% |
| 2018 | $1.14B | $1.17B | +$25.70M | +2.25% | +2.25% |
| 2017 | $1.04B | $1.14B | +$101.00M | +9.68% | +9.68% |
| 2016 | $771.90M | $1.04B | +$271.00M | +35.11% | +35.11% |
| 2015 | $665.10M | $771.90M | +$106.80M | +16.06% | +16.06% |
| 2014 | $880.00M | $665.10M | $-214.90M | -24.42% | -24.42% |
| 2013 | $814.20M | $880.00M | +$65.80M | +8.08% | +8.08% |
| 2012 | $677.60M | $814.20M | +$136.60M | +20.16% | +20.16% |
| 2011 | $528.00M | $677.60M | +$149.60M | +28.33% | +28.33% |
| 2010 | $385.06M | $528.00M | +$142.94M | +37.12% | +37.12% |
| 2009 | $278.24M | $385.06M | +$106.82M | +38.39% | +38.39% |
| 2008 | $205.69M | $278.24M | +$72.55M | +35.27% | +35.27% |
| 2007 | $99.84M | $205.69M | +$105.84M | +106.01% | +106.01% |
| 2006 | $70.79M | $99.84M | +$29.06M | +41.05% | +41.05% |
| 2005 | $30.32M | $70.79M | +$40.47M | +133.50% | +133.50% |
| 2004 | $-7.85M | $30.32M | +$38.17M | +0.00% | N/A |
| 2003 | $-14.15M | $-7.85M | +$6.29M | +0.00% | N/A |
| 2002 | $-18.55M | $-14.15M | +$4.41M | +0.00% | N/A |
| 2001 | $-12.80M | $-18.55M | $-5.75M | +0.00% | N/A |
| 2000 | $-15.93M | $-12.80M | +$3.12M | +0.00% | N/A |
About Intuitive Surgical, Inc.
Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets. Its flagship offering, the da Vinci Surgical System, facilitates intricate operations through a minimally disruptive approach. Expanding beyond surgical applications, the company also provides the Ion endoluminal system, designed for diagnostic interventions like minimally invasive lung biopsies. Complementing its primary systems, Intuitive Surgical supplies a comprehensive array of instruments, including stapling tools, energy devices, and essential core components. Furthermore, it offers structured training programs to ensure proficient use of its technology, alongside extensive customer support services encompassing installation, repairs, and ongoing maintenance. The firm also integrates digital capabilities to deliver unified, connected solutions that optimize hospital performance through actionable insights. Established in 1995, Intuitive Surgical maintains its corporate headquarters in Sunnyvale, California.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- David J. Rosa